Arsenic trioxide phosphorylates c-Fos to transactivate p21(WAF1/CIP1) expression

Zi-Miao Liu1, Huei-Sheng Huang

  • 1Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.

Insights

High concentrations of arsenic trioxide (ATO) activate ERK1/2, boosting c-Fos and enhancing p21 gene expression by forming a complex with c-Jun and p300/CBP. This clarifies ATO

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Arsenic trioxide (ATO) has a dual role as a poison and a therapeutic agent, particularly in treating acute promyelocytic leukemia.
  • ATO's anti-tumor effects are concentration-dependent, necessitating a thorough understanding of its mechanisms of action for safe therapeutic use.
  • Previous research indicated opposing roles of ERK1/2 and JNK pathways in regulating p21(WAF1/CIP1) (p21) expression under ATO treatment in A431 cells.

Purpose of the Study:

  • To elucidate the concentration-dependent mechanisms of arsenic trioxide (ATO) in regulating gene expression.
  • To investigate the role of high-concentration ATO in sustaining ERK1/2 phosphorylation and its downstream effects on c-Fos and p21 gene expression.
  • To determine the specific phosphorylation sites on c-Fos crucial for its interaction with the p21 promoter.

Main Methods:

  • Utilized site-directed mutagenesis to identify critical phosphorylation sites on c-Fos.
  • Employed DNA affinity precipitation assays to assess the binding of c-Fos to the p21 promoter.
  • Conducted functional assays to evaluate the transactivation of p21 gene expression.

Main Results:

  • High concentrations of ATO sustain ERK1/2 phosphorylation, leading to increased c-Fos biosynthesis and stability.
  • Phosphorylation of specific C-terminal (Thr232, Thr325, Thr331, Ser374) and N-terminal (Ser70) sites on c-Fos is essential for its binding to the p21 promoter.
  • This interaction, along with dimerized dephosphorylated c-Jun, recruits p300/CBP to the Sp1 sites, activating p21 gene expression.

Conclusions:

  • High-concentration ATO activates the ERK1/2 pathway, enhancing c-Fos expression and subsequent p21 gene transactivation in A431 cells.
  • The study identifies key phosphorylation events in c-Fos that mediate its interaction with the p21 promoter.
  • These findings provide critical insights into the molecular mechanisms underlying ATO's therapeutic effects and highlight the importance of concentration-specific actions.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...